| Used as Therapeutic Agent |
| eye
drops |
chitosan–N-acetylcysteine |
(181, 182, 185, 194, 195) |
| |
chitosan–cysteine |
(197) |
| |
| Drug Delivery Systems |
| Oral Delivery |
| hydrogel |
leuprolide |
(158) |
| liposomes |
calcitonin |
(91) |
| docetaxel |
(75) |
| micelles |
paclitaxel |
(80) |
| microparticles |
acyclovir |
(198) |
| nanoemulsion |
curcumin |
(55) |
| nanoparticles |
amoxicillin |
(192) |
| cherry
extract delivery |
(87) |
| docetaxel |
(63, 74, 146, 199) |
| fluorescein diacetate
as
model compound |
(82) |
| insulin |
(84, 200, 201) |
| low-molecular-weight
heparin |
(160) |
| Map4k4 siRNA |
(38) |
| paromomycin |
(78) |
| sitagliptin |
(202) |
| TNF-α siRNA |
(31, 112) |
| polymer solution |
Rhodamine-123 as model P-gp substrate |
(203) |
| polymer tablets |
antide |
(151, 155) |
| calcitonin |
(204) |
| insulin |
(43, 205) |
| naproxen |
(86) |
| Rhodamine-123 as
model P-gp substrate |
(203) |
| self-emulsifying drug delivery
system |
insulin |
(206) |
| Ocular Delivery |
| nanoparticles |
curcumin |
(143, 144) |
| polymer solution |
dexamethasone |
(111) |
| Nasal Delivery |
| hydrogel
containing proniosomes |
duloxetine |
(207) |
| microparticles |
insulin |
(208, 209) |
| paliperidone |
(210) |
| nanoparticles |
bovine serum albumin as
model compound for vaccination |
(67) |
| galantamine |
(211) |
| insulin |
(156) |
| leuprolide |
(212) |
| pDNA encoding for green
fluorescent protein |
(213) |
| selegiline |
(157) |
| theophylline |
(214) |
| tizanidine |
(215) |
| Buccal delivery |
| freeze-dried
hydrogels |
bovine
serum albumin as
model macromolecular compound |
(216, 217) |
| insulin |
(218) |
| nanofiber mats |
Garcinia mangostana extract |
(128) |
| α-mangostin |
(219) |
| polymer films |
calcium fluoride |
(220) |
| fluconazole |
(221) |
| lignocaine |
(220) |
| risedronate |
(73) |
| polymer films containing
nanoparticles |
insulin |
(28, 33) |
| polymer
solution |
pituitarity
adenlyate cyclase-activating
polypeptide |
(222) |
| polymer tablets |
pituitarity adenlyate cyclase-activating
polypeptide |
(159) |
| Vaginal Delivery |
| microparticles |
tenofovir |
(223) |
| nanofibers |
tenofovir |
(224) |
| nanoparticles |
tenofovir |
(225) |
| polymer
tablets |
metronidazole |
(96) |
| Intravesical
Delivery |
| microparticles |
fluorescein diacetate as
model compound |
(226) |
| nanoparticles |
fluorescein diacetate as
model compound |
(226) |
| gemcitabine |
(227) |
| Pulmonary Delivery |
| Nanoparticles |
calcitonin |
(76) |
| Transdermal
Delivery |
| polymer film |
carvedilol |
(228) |
| microneedle
patch |
tacrolimus |
(196) |
| Colonic Delivery |
| microcapsules |
probiotic bacteria |
(229) |
| Parenteral
delivery |
| hydrogels |
bendamustine |
(136) |
| curcumin |
(191, 230, 231) |
| nanoparticles |
5-fluorouracil |
(232) |
| curcumin |
(232) |
| meglumine
antimoniate |
(172) |
| pDNA encoding for green
fluorescent protein |
(34, 79) |
| TNF-α siRNA |
(112) |
| VEGF siRNA |
(233) |
